Canopy Growth Corp
CGCNasdaqCIK 1737927HealthcareFiscal year ends Mar 31
Reports and events: 366 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2317:19 ET | 8-K | 5.07 Shareholder vote results | 0001104659-26-118521 |
| 2026-10-1621:00 ET | 8-K | 3.01 Delisting notice | 0001104659-26-116639 |
| 2026-08-0720:50 ET | DEF 14A | Proxy statementPeriod 2026-09-25 | 0001104659-26-092759 |
| 2026-08-0720:05 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001104659-26-092687 |
| 2026-08-0711:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-339131 |
| 2026-08-0710:45 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-339076 |
| 2026-06-1511:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-270277 |
| 2026-06-1510:46 ET | 10-K | Annual reportPeriod 2026-03-31 | 0001193125-26-270260 |
| 2026-05-2720:16 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-26-066964 |
| 2026-05-1521:06 ET | 8-K | 4.02 Non-reliance on financial statements; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-062784 |
| 2026-03-1611:59 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-028015 |
| 2026-02-0612:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-040294 |
| 2026-02-0611:45 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0001193125-26-040275 |
| 2026-01-0821:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-002134 |
| 2025-12-1512:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-120861 |
| 2025-11-0712:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-270995 |
| 2025-11-0711:45 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-270960 |
| 2025-10-1410:06 ET | 8-K | 5.07 Shareholder vote results | 0001104659-25-098884 |
| 2025-09-1720:35 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-090861 |
| 2025-08-2921:03 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-085779 |
| 2025-08-0811:06 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-176020 |
| 2025-08-0810:45 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001193125-25-175982 |
| 2025-08-0720:29 ET | DEF 14A | Proxy statementPeriod 2025-09-26 | 0001104659-25-075215 |
| 2025-07-2921:03 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-071781 |
| 2025-07-0913:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-066600 |
| 2025-05-3011:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-079321 |
| 2025-05-3010:45 ET | 10-K | Annual reportPeriod 2025-03-31 | 0000950170-25-079317 |
| 2025-04-0111:54 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-030245 |
| 2025-02-2822:19 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-019244 |
| 2025-02-0712:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-015847 |
| 2025-02-0711:45 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0000950170-25-015839 |
| 2024-12-1021:42 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-127226 |
| 2024-12-0921:15 ET | 8-K | 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-126760 |
| 2024-11-2621:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-123094 |
| 2024-11-0812:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-123682 |
| 2024-11-0811:45 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-123672 |
| 2024-10-1711:56 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-109376 |
| 2024-09-2512:41 ET | 8-K | 5.07 Shareholder vote results | 0001104659-24-102623 |
| 2024-08-2320:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-092438 |
| 2024-08-1612:53 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-090360 |
| 2024-08-0911:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-094343 |
| 2024-08-0910:30 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-094330 |
| 2024-08-0113:03 ET | DEF 14A | Proxy statementPeriod 2024-09-24 | 0001104659-24-084685 |
| 2024-06-0612:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-068924 |
| 2024-06-0520:28 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-068696 |
| 2024-06-0511:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-068499 |
| 2024-05-3011:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-066246 |
| 2024-05-3010:46 ET | 10-K | Annual reportPeriod 2024-03-31 | 0000950170-24-066240 |
| 2024-05-1320:26 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-24-060572 |
| 2024-05-0720:10 ET | S-1 | Registration statement | 0001104659-24-058001 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.